Glucosidase inhibitors: new approaches to malting efficiency

葡萄糖苷酶抑制剂:提高麦芽效率的新方法

基本信息

  • 批准号:
    BB/I017291/1
  • 负责人:
  • 金额:
    $ 63.3万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2011
  • 资助国家:
    英国
  • 起止时间:
    2011 至 无数据
  • 项目状态:
    已结题

项目摘要

The brewing and distilling industries are of enormous economic importance to the UK. They have a major impact on farming because they use almost 2M tonnes of UK-grown barley (about one third of the crop, occupying one third of a million hectares of land) every year, they provide employment for tens of thousands of people, and their products are enjoyed not only in the UK but in many countries around the world. There is strong pressure on the industry to increase the efficiency with which barley grain is converted into beer and whisky. This is in part to maintain profitability, but also to reduce the production of waste and the amount of energy used in the conversion process. The basic conversion process occurs in four main stages. First, during malting, the barley grains are soaked in water then allowed to start to germinate. Inside the germinating grain, enzymes are produced that can convert the starch stored in the grain to sugars. Second, during kilning, the grain is heated to dry it out so that germination stops. Third, the grain is milled then mixed with hot water. During this mashing process, the enzymes convert the starch to sugars. Finally, the sugar-containing liquid is drained off and yeast is added. The yeast converts the sugars to alcohol. One of the major losses during the conversion of grain to beer and whisky occurs during malting. As soon as the enzymes are produced, they start to convert starch to sugars inside the seed, and the sugars fuel the growth of rootlets. Thus some of the starch store is lost before the mashing stage, reducing the potential yield of alcohol and resulting in the production of unwanted rootlets. This loss is between 5% and 10% of the starch. In the context of a market value of £20bn for the brewing industry alone, even a small reduction in the extent of starch loss during malting would have huge economic benefits. Because of the economic importance of this malting loss, several different methods to prevent rootlet growth have been tested. However these have not been applied commercially, because of cost, toxicity, or adverse effects on the quality of the malt. We have discovered that both rootlet growth and starch loss in germinating barley seeds can be reduced or prevented by the application of tiny amounts of natural plant products, called iminosugars. These products have the potential to reduce malting losses without undesirable side effects. Understanding how they work inside the seed will also provide new information that will help in developing better varieties of barley for brewing and distilling. In this project we will test natural products in a 'micromalting' system that mimics real malting, and identify which ones are suitable for commercial trials. We will use biochemical and molecular methods to discover precisely how these products prevent the growth of rootlets, and the loss of starch. This information will enable us to identify genes in barley that are important in determining the malting quality of the grain. To ensure that our research is relevant to the needs of the brewing and distilling industries, we will regularly consult an Advisory Panel that includes an expert on these industries, and also experts on barley grain germination, plant natural products, and malting.
酿酒和蒸馏行业对英国具有巨大的经济重要性。他们对农业有重大影响,因为他们每年使用近200万吨英国种植的大麦(约占作物的三分之一,占百万公顷土地的三分之一),他们为数万人提供就业机会,他们的产品不仅在英国,而且在世界各地的许多国家都很受欢迎。该行业面临着巨大的压力,要求提高大麦转化为啤酒和威士忌的效率。这在一定程度上是为了保持盈利能力,但也是为了减少废物的产生和转换过程中使用的能源。基本的转换过程分为四个主要阶段。首先,在制麦过程中,大麦粒被浸泡在水中,然后开始发芽。在发芽的谷物内部,产生了可以将谷物中储存的淀粉转化为糖的酶。第二,在烘干过程中,谷物被加热干燥,从而停止发芽。第三,谷物被磨碎,然后与热水混合。在糖化过程中,酶将淀粉转化为糖。最后,将含糖液体排出并加入酵母。酵母将糖转化为酒精。在谷物转化为啤酒和威士忌的过程中,主要的损失之一发生在制麦过程中。一旦这些酶产生,它们就开始在种子内将淀粉转化为糖,而糖则为小根的生长提供燃料。因此,在糖化阶段之前损失了一些淀粉储存,降低了酒精的潜在产量,并导致产生不需要的小根。这种损失在淀粉的5%至10%之间。在仅酿酒行业的市场价值就达到200亿英镑的背景下,即使在制麦过程中淀粉损失的程度略有减少,也会产生巨大的经济效益。由于这种发芽损失的经济重要性,已经测试了几种不同的方法来防止小根生长。然而,由于成本、毒性或对麦芽质量的不利影响,这些还没有在商业上应用。我们已经发现,通过应用少量的天然植物产品(称为亚氨基糖),可以减少或防止发芽大麦种子中的小根生长和淀粉损失。这些产品有可能减少麦芽损失,而没有不良的副作用。了解它们如何在种子内工作也将提供新的信息,这将有助于开发更好的大麦品种用于酿造和蒸馏。在这个项目中,我们将在一个模拟真实的麦芽制造的“微麦芽制造”系统中测试天然产品,并确定哪些产品适合商业试验。我们将使用生物化学和分子方法来精确地发现这些产品是如何防止小根的生长和淀粉的损失的。这些信息将使我们能够确定大麦中对决定谷物麦芽质量很重要的基因。为了确保我们的研究与酿造和蒸馏行业的需求相关,我们将定期咨询咨询咨询小组,其中包括这些行业的专家,以及大麦发芽,植物天然产品和麦芽制造方面的专家。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Maltase Involved in Starch Metabolism in Barley Endosperm Is Encoded by a Single Gene.
  • DOI:
    10.1371/journal.pone.0151642
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Andriotis VM;Saalbach G;Waugh R;Field RA;Smith AM
  • 通讯作者:
    Smith AM
Cell wall degradation is required for normal starch mobilisation in barley endosperm.
  • DOI:
    10.1038/srep33215
  • 发表时间:
    2016-09-13
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Andriotis VM;Rejzek M;Barclay E;Rugen MD;Field RA;Smith AM
  • 通讯作者:
    Smith AM
High-Throughput In Vitro Screening for Inhibitors of Cereal a-Glucosidase.
谷物α-葡萄糖苷酶抑制剂的高通量体外筛选。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alison Smith其他文献

Uncertainty in current and future health wearables
当前和未来健康可穿戴设备的不确定性
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    22.7
  • 作者:
    Bran Knowles;Alison Smith;Forough Poursabzi;D. Lu;Halimat Alabi
  • 通讯作者:
    Halimat Alabi
Perioperative Fluid Management in Surgical Patients: A Review
手术患者围手术期液体管理:综述
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Alex Cao;Lillian T Bellfi;J. Schoen;P. Greiffenstein;Alan B Marr;L. Stuke;J. Hunt;R. Pino;Alison Smith
  • 通讯作者:
    Alison Smith
Self-Fulfilling Prophecies, Perceptual Biases, and Accuracy at the Individual and Group Levels
自我实现的预言、感知偏差以及个人和群体层面的准确性
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Alison Smith;L. Jussim;J. Eccles;Michelle VanNoy;Stephanie Madon;P. Palumbo
  • 通讯作者:
    P. Palumbo
Uveitis Anterior Asociado a Retinitis Pigmentosa: Reporte de un Caso
前葡萄膜炎与色素性视网膜炎:Reporte de un Caso
  • DOI:
    10.56172/oftalmica.v22i.39
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Alison Smith
  • 通讯作者:
    Alison Smith
Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive.
患有室间隔缺损和生长障碍的儿童和猪前向输出量减少的机制。
  • DOI:
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    W. Corin;M. Swindle;James;F.;Spann;Kiyoharu Nakano;Mary;Frankis;Robert W. W. Biederman;Alison Smith;Ashby;Taylor;Blase A. Carabello
  • 通讯作者:
    Blase A. Carabello

Alison Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alison Smith', 18)}}的其他基金

Collaborative Research: Neotoma Paleoecology Database, a Multi-Proxy, International, Community-Curated Data Resource for Global Change Research
合作研究:Neotoma 古生态学数据库,一个用于全球变化研究的多代理、国际、社区策划的数据资源
  • 批准号:
    1948297
  • 财政年份:
    2020
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Continuing Grant
18-BBSRC-NSF/BIO Focusing a quantitative lens on synthetic phototrophic communities
18-BBSRC-NSF/BIO 将定量视角聚焦于合成光养群落
  • 批准号:
    BB/T010525/1
  • 财政年份:
    2020
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
(Re)design of the choroplast genome - towards a synthetic organelle
叶绿体基因组的(重新)设计 - 走向合成细胞器
  • 批准号:
    BB/R01860X/1
  • 财政年份:
    2018
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
17-ERACoBioTech: MicroalgaE as Renewable Innovative green cell facTories
17-ERACoBioTech:微藻作为可再生创新绿色细胞工厂
  • 批准号:
    BB/R021694/1
  • 财政年份:
    2018
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
EKN Tool Assessor: Facilitating the application of innovative tools in the assessment of ecosystem services, green infrastructure and natural capital
EKN Tool Assessor:促进创新工具在生态系统服务、绿色基础设施和自然资本评估中的应用
  • 批准号:
    NE/P01254X/1
  • 财政年份:
    2016
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Fellowship
Collaborative Research: Neotoma Paleoecology Database, Community-led Cyberinfrastructure for Global Change Research
合作研究:Neotoma 古生态学数据库、社区主导的全球变化研究网络基础设施
  • 批准号:
    1550721
  • 财政年份:
    2016
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Continuing Grant
The twilight zone: the initiation of starch degradation in leaves
暮光区:叶子中淀粉降解的开始
  • 批准号:
    BB/N001389/1
  • 财政年份:
    2016
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
EarthCubeIA: Collaborative Proposal: Building Interoperable Cyberinfrastructure (CI) at the Interface between Paleogeoinformatics and Bioinformatics
EarthCubeIA:协作提案:在古地理信息学和生物信息学之间的接口处构建可互操作的网络基础设施 (CI)
  • 批准号:
    1540994
  • 财政年份:
    2015
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Standard Grant
Developing platforms for the production of diterpenoids
开发二萜类化合物生产平台
  • 批准号:
    BB/M018180/1
  • 财政年份:
    2015
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
14-PSIL Combining Algal and Plant Photosynthesis (CAPP2)
14-PSIL 结合藻类和植物光合作用 (CAPP2)
  • 批准号:
    BB/M006352/1
  • 财政年份:
    2014
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant

相似国自然基金

内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
多羟基吡咯里西啶及其3-取代衍生物的合成及糖苷酶抑制活性的生物学评价
  • 批准号:
    81060254
  • 批准年份:
    2010
  • 资助金额:
    28.0 万元
  • 项目类别:
    地区科学基金项目
2-取代的七元氮杂糖及其缩环产物六元氮杂糖的合成和糖苷酶抑制活性的生物学评价
  • 批准号:
    30860341
  • 批准年份:
    2008
  • 资助金额:
    23.0 万元
  • 项目类别:
    地区科学基金项目
基于penicillide结构的类天然产物合成及其胆固醇酯转运蛋白抑制的研究
  • 批准号:
    20872019
  • 批准年份:
    2008
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
昆虫酚氧化酶抑制剂的抑制机理及其构效关系研究
  • 批准号:
    30571237
  • 批准年份:
    2005
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
建立甲状腺髓样癌的细胞和动物模型以及研究RET原癌基因突变的致病机制
  • 批准号:
    30370666
  • 批准年份:
    2003
  • 资助金额:
    20.0 万元
  • 项目类别:
    面上项目

相似海外基金

New molecular shapes from strained aromatic foldamer macrocycles and their application to development of PPI inhibitors
应变芳香折叠大环化合物的新分子形状及其在 PPI 抑制剂开发中的应用
  • 批准号:
    23KK0134
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
  • 批准号:
    10713648
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
Mechanistic Studies of Gyrase/Topoisomerase IV-Targeted Antibacterials
旋转酶/拓扑异构酶 IV 靶向抗菌药物的机理研究
  • 批准号:
    10667862
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
Ref-1 in Retinal Neovascularization
Ref-1 在视网膜新生血管中的作用
  • 批准号:
    10679621
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
Endocrine tissue molecular pathways dysregulated by immune checkpoint inhibitors causing ICI-triggered adverse events
免疫检查点抑制剂导致内分泌组织分子通路失调,导致 ICI 引发的不良事件
  • 批准号:
    10648465
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
  • 批准号:
    10642368
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
  • 批准号:
    10844023
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
  • 批准号:
    MR/X030202/1
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
靶向 1-磷酸鞘氨醇 (S1P1) 受体治疗芳香酶抑制剂引起的肌肉骨骼症状
  • 批准号:
    10668781
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 63.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了